Deep vein thrombosis - Treatment with a cytotoxic agent for a malignant disease Factor
Last reviewed for CCPS 22 December 2008.
Preliminary questions [21473]
21474 there is some evidence that being treated with a cytotoxic agent for a malignant disease may be a factor in the development of the condition under consideration.
21475 the veteran has been treated with a cytotoxic agent for a malignant disease at some time.
21476 — the malignant disease for which the veteran was treated with a cytotoxic agent is an illness or injury which is identifiable. [Default true]
21244 for the identified illness or injury, a malignant disease, the veteran was treated with a cytotoxic agent within the 90 days before the clinical onset of the condition under consideration.
25107 — the veteran has established the causal connection between being treated with a cytotoxic agent for a malignant disease and VEA service for the clinical onset of deep vein thrombosis.
21369 — the veteran has established the causal connection between being treated with a cytotoxic agent for a malignant disease and operational service for the clinical onset of deep vein thrombosis.
or
21370 — the veteran has established the causal connection between being treated with a cytotoxic agent for a malignant disease and eligible service for the clinical onset of deep vein thrombosis.
Clinical onset and operational service [21369]
21371 — the identified illness or injury, a malignant disease, is causally related to operational service.
Clinical onset and eligible service [21370]
21372 — the identified illness or injury, a malignant disease, is causally related to eligible service.